Background The availability of clinical and therapeutic data drawn from medical records and
administrative databases has entailed new opportunities for clinical and epidemiologic …

Misclassification is present in nearly every epidemiologic study, yet is rarely quantified in
analysis in favor of a focus on random error. In this review, we discuss past and present …

Study objective Acute pain complaints are commonly treated in the emergency department
(ED). Short courses of opioids are presumed to be safe for acute pain; however, the risk of …

Background The recent availability of dabigatran, a novel oral anticoagulant, provided a new
treatment option for stroke prevention in atrial fibrillation beyond warfarin, the main therapy …

The MarketScan databases are a family of administrative claims databases that contain data
on inpatient and outpatient claims, outpatient prescription claims, clinical utilization records …

Importance The introduction of direct oral anticoagulants (DOACs) has transformed the
treatment of venous thromboembolism (VTE). Large health care databases offer valuable …

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …

Background: Data prior to 2011 suggest that a low percentage of patients hospitalized for
acute coronary syndromes filled high-intensity statin prescriptions upon discharge. Black …

Limited real-world data are available regarding the comparative safety of non-vitamin K
antagonist oral anticoagulants (NOACs). The objective of this retrospective claims …

Introduction Direct oral anticoagulants (DOAC) have gained an increased share over
warfarin for prevention and treatment of thromboembolic disease. We studied DOAC …